Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997

International Journal of Cancer

Volumn 92, Issue 2, 2001, Pages 303-308

  Broeders, Mireille J M ^a   Peer, Petronella G M ^a   Straatman, Huub ^a   Beex, Louk V A M ^a   Hendriks, Jan H C L ^a   Holland, Roland ^a   Verbeek, Andr L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Mammographic screening; Mortality; The Netherlands; Trend study

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CAUSE OF DEATH; EARLY DIAGNOSIS; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY; NETHERLANDS; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; DEMOGRAPHY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NETHERLANDS; ODDS RATIO; SURVIVAL RATE;

EID: 0035871982     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1186>3.0.CO;2-B     Document Type: Article

References (43)

1. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening
2. Breast cancer mortality rates are levelling off or beginning to decline in many Western countries: Analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries
3. Age, cohort-of-birth, and period-of-death trends in breast cancer mortality in Europe
4. Declining breast cancer mortality: What's behind it?
5. Implementation of screening as a public health policy: Issues in design and evaluation
6. Long term breast cancer screening in Nijmegen, the Netherlands: The nine rounds from 1975-92
7. Comparison between registries: Age-standardized rates
8. Models for temporal variation in cancer rates. I: Age-period and age-cohort models
9. Models for temporal variation in cancer rates. II: Age-period-cohort models
10. Extra-Poisson variation in log-linear models
11. Screening: Assessment of current studies
12. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: Comparison with the United Kingdom
13. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes
14. Effectiveness of the public health policy for breast cancer screening in Finland: Population based cohort study
15. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: Comparison of observed with predicted mortality
16. Screening for cancer of the breast
17. Further evidence of benefits of a (non-randomised) breast cancer screening programme: The DOM project
18. Breast cancer mortality and the change in fertility risk factors at menopause: A prospective study of 800,000 married Norwegian women
19. Implications of birth cohort patterns in interpreting trends in breast cancer rates
20. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use
21. Breast cancer epidemiology: Summary and future directions
22. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
23. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort
24. Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995
25. Changing patterns in the presentation of breast cancer over 25 years
26. Borstkanker in Zuidoost-Noord-Brabant en in Noord-Limburg; Beloop van incidentie en vervroeging van de diagnose in een niet-gescreende vrouwelijke bevolking, 1975-1986
27. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: Earlier diagnosis or better treatment?
28. Breast cancer (in Dutch)
29. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: Assessment of early indicators of screening effectiveness
30. Rising incidence of breast cancer: Relationship to stage and receptor status
31. Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s
32. Rising levels of estrogen receptor in breast cancer over 2 decades
33. Improved prognosis in breast cancer since 1970 in south-east Netherlands
34. Basic issues in population screening for cancer
35. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
36. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmö, Sweden, 1961-1992
37. Management of early breast cancer in southeast Netherlands since 1984. A population-based study
38. A method for partitioning cancer mortality trends by factors associated with diagnosis: An application to female breast cancer
39. General principles of cancer screening
40. Assessment of nationwide cancer-screening programmes
41. How effective is screening for breast cancer?
42. Generalized linear models